COVID-19 Notice: We are providing FREE consultations via phone or video conferencing for your safety and convenience. Learn More »

Articles Posted in AstraZeneca

Published on:

Here are this week’s stories:

Published on:

Here’s what we’re looking at, this week:

Happy Monday!

Published on:

Some items of interest while you eat turkey sandwiches for lunch, today:

Published on:

Tons of press on AstraZeneca and their antipsychotic drug Seroquel, lately, much of it dealing with one Dr. Michael Reinstein, a physician who, by all reports, will have to answer a lot of questions about his patients.
Here are the Cliffs Notes:

Continue Reading

Published on:

An e-mail from the Seroquel litigation, dated May 14, 2001, contains some talking points for Seroquel’s Product Managers and Marketing Managers. AstraZeneca understood that they had a big problem with the weight-gain issue. The e-mail reflects their approach:

  • “The global strategy is to demonstrate to customers that Seroquel has a weight neutral profile in the long term
  • Seroquel is neither associated with diabetes nor its exacerbation